Videoteca MOC

Periódico	Artigo
	Volume 2 – Número 2 – *Journal of Clinical Oncology* ( Volume 28 • Número 12 • Abril 2010) Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignan Glioma: RESCUE Study – Perry, R. et al.
	Volume 1 – Número 4 - *The Lancet* ( Volume 370 • Número 9605 • Dezembro 2007) Bevacizumab Plus Interferon Alfa-2a for Treatment of Metastatic Cell Carcinoma: a Randomised, Double-Blind Phase III Trial – Escudier, B. et al.
	Volume 1 – Número 3 - *Journal of Clinical Oncology* ( Volume 27 • Número 28 • Outubro 2009) Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma - Friedman, H.S. et al
	Volume 1 – Número 2 – *Journal of Clinical Oncology* ( Volume 27 • Número 30 • Outubro 2009) Independent Review of E2100: A Phase III Trial of Bevacizumab Plus Paclitaxel Versus Paclitaxel in Women With Metastatic Breast Cancer – Gray, R. et al.
	Volume 1 – Número 1 – Journal of Clinical Oncology ( Volume 26 • Número 21 • Julho 2008) Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer – Scagliotti, V. et. al.